Date: 12th October 2021
Time: from 9:30 PM to 10:30 PM
Audience: Veterinarians and Nurses
Price: AED 0
Dr Neil Forbes BVetMed., DipECZM (avian), FRCVS
Neil qualified from RVC in 1983. He is a Diplomate of the European College of Zoological Medicine, Specialist in Avian Medicine and FRCVS. Neil is now retired from full time referral clinical avian work and spends his time involved in a number of part-time consultancy roles.
Dr Katja Koeppel BVMS, MSc (wildlife), Dr med vet, Diplomate ECZM (ZHM)
Katja Koeppel was born in Germany. She studied veterinary medicine at the University of Glasgow and started her veterinary career in Hamburg, Germany. She completed a Masters in wildlife and tropical disease at the University of Pretoria. She is currently a Senior Lecturer in Wildlife at UP.
Dr Karin Lourens BVSc, MSc (wildlife)
Karin's interest in wildlife started in 2012 when she became a volunteer at the FreeMe Wildlife Rehabilitation Centre in Johannesburg. Together with wildlife rehabilitation specialist, Nicci Wright, she created the Johannesburg Wildlife Veterinary Hospital and wildlife rehabilitation centre.
The safety and efficacy of the core products results in veterinary treatment products also being licensed for use in the same regions. In the webinars produced to date we have learnt how F10 can be safely and effectively applied in a range of predominantly exotic species patients (birds, reptiles, amphibia and small exotic mammals), for the effective prevention and treatment of a range of clinical conditions caused by contagious pathogens (bacteria, yeasts and fungi and viruses), for skin, respiratory, oral and digestive, eye and ear, as well as septic spaces, infections and diseases. As we now move to consider the F10 treatment applications in wildlife patients, we can of course use F10 products to control the same range of diseases. However, as those involved in these challenging cases will know, wildlife patients bring with them a whole range of different challenges. Typically, wildlife patients are sicker by the time they allow anyone to be aware they are ill or manage to catch them. Typically, they are extremely stressed by captive management and therapy, so the invasiveness of therapy, the patient handling frequency and the duration of treatment and captivity should all be minimised, whilst also accepting that if cessation of treatment and release is premature, there is not likely to be a second chance for the patient. So, in these respects, the use of F10 products to minimise additional stress related disease, the control of endogenous diseases in the patient at the time of capture, the application of non-invasive low stress treatments e.g. nebulisation, the prevention of secondary disease e.g. fly strike and the use of long-term applications, e.g. germicidal barrier ointment (with or without insecticide), to reduce the frequency of treatment, or to facilitate release prior to total clinical resolution, are fundamentally important treatment options in these patients. The use of F10 products in these and similar relevant ways, with reference to clinical cases, will be discussed by the panellists in this webinar.
At Eurovets, we represent leading multi-national brands in nutrition, veterinary equipment, medicines and consumables for companion-, equine and production animals. In addition to traditional wholesale, Eurovets provides warehousing, distribution, CPD training, webinars, marketing and sales resources in order to support these products in the region.
Eurovets is excited to have Dr Neil Forbes, Dr Katja Koeppel, Dr Karin Lourens conducting this webinar and share their knowledge and broad experience with our customers here in the UAE.